GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OTCPK:ORXOY) » Definitions » Net Margin %

ORXOY (Orexo AB) Net Margin % : -72.49% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orexo AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Orexo AB's Net Income for the three months ended in Dec. 2024 was $-10.58 Mil. Orexo AB's Revenue for the three months ended in Dec. 2024 was $14.59 Mil. Therefore, Orexo AB's net margin for the quarter that ended in Dec. 2024 was -72.49%.

The historical rank and industry rank for Orexo AB's Net Margin % or its related term are showing as below:

ORXOY' s Net Margin % Range Over the Past 10 Years
Min: -39.56   Med: -16.4   Max: 25.94
Current: -34.38


ORXOY's Net Margin % is ranked worse than
83.18% of 981 companies
in the Drug Manufacturers industry
Industry Median: 4.56 vs ORXOY: -34.38

Orexo AB Net Margin % Historical Data

The historical data trend for Orexo AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Net Margin % Chart

Orexo AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.72 -39.56 -28.45 -20.08 -34.41

Orexo AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.20 -6.39 -23.31 -30.70 -72.49

Competitive Comparison of Orexo AB's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexo AB's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Orexo AB's Net Margin % falls into.


;
;

Orexo AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Orexo AB's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-18.48/53.71
=-34.41 %

Orexo AB's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-10.578/14.593
=-72.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orexo AB  (OTCPK:ORXOY) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Orexo AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Orexo AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orexo AB Business Description

Traded in Other Exchanges
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.